TrialThe oncologist2023

A Single-Arm, Open-Label Phase II Study of ONC201 in Recurrent/Refractory Metastatic Breast Cancer and Advanced Endometrial Carcinoma.

Sarah L P Atkins et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.